BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Skytthe MK, Graversen JH, Moestrup SK. Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases. Int J Mol Sci 2020;21:E5497. [PMID: 32752088 DOI: 10.3390/ijms21155497] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Polano M, Fabbiani E, Adreuzzi E, Cintio FD, Bedon L, Gentilini D, Mongiat M, Ius T, Arcicasa M, Skrap M, Dal Bo M, Toffoli G. A New Epigenetic Model to Stratify Glioma Patients According to Their Immunosuppressive State. Cells 2021;10:576. [PMID: 33807997 DOI: 10.3390/cells10030576] [Reference Citation Analysis]
2 Guimarães GR, Almeida PP, de Oliveira Santos L, Rodrigues LP, de Carvalho JL, Boroni M. Hallmarks of Aging in Macrophages: Consequences to Skin Inflammaging. Cells 2021;10:1323. [PMID: 34073434 DOI: 10.3390/cells10061323] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Benedetti S, Gemma Nasoni M, Palma F, Citarella R, Luchetti F. Serum changes in sTWEAK and its scavenger receptor sCD163 in ultramarathon athletes running the 24-h race. Cytokine 2021;137:155315. [PMID: 33011401 DOI: 10.1016/j.cyto.2020.155315] [Reference Citation Analysis]
4 Fuselier C, Quemener S, Dufay E, Bour C, Boulagnon-Rombi C, Bouland N, Djermoune EH, Devy J, Martiny L, Schneider C. Anti-Tumoral and Anti-Angiogenic Effects of Low-Diluted Phenacetinum on Melanoma. Front Oncol 2021;11:597503. [PMID: 33747916 DOI: 10.3389/fonc.2021.597503] [Reference Citation Analysis]
5 Calik M, Calik I, Artas G, Ozercan IH, Triantafyllou K. Prognostic Value of TRPM7 Expression and Factor XIIIa-Expressing Tumor-Associated Macrophages in Gastric Cancer. Gastroenterology Research and Practice 2021;2021:1-25. [DOI: 10.1155/2021/7249726] [Reference Citation Analysis]
6 Do T, Guran R, Jarosova R, Ondrackova P, Sladek Z, Faldyna M, Adam V, Zitka O. MALDI MSI Reveals the Spatial Distribution of Protein Markers in Tracheobronchial Lymph Nodes and Lung of Pigs after Respiratory Infection. Molecules 2020;25:E5723. [PMID: 33287430 DOI: 10.3390/molecules25235723] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Vegting Y, Vogt L, Anders HJ, de Winther MPJ, Bemelman FJ, Hilhorst ML. Monocytes and macrophages in ANCA-associated vasculitis. Autoimmun Rev 2021;20:102911. [PMID: 34298153 DOI: 10.1016/j.autrev.2021.102911] [Reference Citation Analysis]
8 Haslbauer JD, Zinner C, Stalder AK, Schneeberger J, Menter T, Bassetti S, Mertz KD, Went P, Matter MS, Tzankov A. Vascular Damage, Thromboinflammation, Plasmablast Activation, T-Cell Dysregulation and Pathological Histiocytic Response in Pulmonary Draining Lymph Nodes of COVID-19. Front Immunol 2021;12:763098. [DOI: 10.3389/fimmu.2021.763098] [Reference Citation Analysis]
9 Smirnova T, Spertini C, Spertini O. CSF1R Inhibition Combined with GM-CSF Reprograms Macrophages and Disrupts Protumoral Interplays with AML Cells. Cancers (Basel) 2021;13:5289. [PMID: 34771453 DOI: 10.3390/cancers13215289] [Reference Citation Analysis]
10 Zhang N, Gao X, Zhang W, Xiong J, Cao X, Fu ZF, Cui M. JEV Infection Induces M-MDSC Differentiation Into CD3+ Macrophages in the Brain. Front Immunol 2022;13:838990. [DOI: 10.3389/fimmu.2022.838990] [Reference Citation Analysis]
11 Gopalaswamy R, Subbian S. Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis. Int J Mol Sci 2021;22:3773. [PMID: 33917321 DOI: 10.3390/ijms22073773] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
12 Prat M, Salon M, Allain T, Dubreuil O, Noël G, Preisser L, Jean B, Cassard L, Lemée F, Tabah-Fish I, Pipy B, Jeannin P, Prost JF, Barret JM, Coste A. Murlentamab, a Low Fucosylated Anti-Müllerian Hormone Type II Receptor (AMHRII) Antibody, Exhibits Anti-Tumor Activity through Tumor-Associated Macrophage Reprogrammation and T Cell Activation. Cancers (Basel) 2021;13:1845. [PMID: 33924378 DOI: 10.3390/cancers13081845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Naicker SD, Feerick CL, Lynch K, Swan D, McEllistrim C, Henderson R, Leonard NA, Treacy O, Natoni A, Rigalou A, Cabral J, Chiu C, Sasser K, Ritter T, O'Dwyer M, Ryan AE. Cyclophosphamide alters the tumor cell secretome to potentiate the anti-myeloma activity of daratumumab through augmentation of macrophage-mediated antibody dependent cellular phagocytosis. Oncoimmunology 2021;10:1859263. [PMID: 33552684 DOI: 10.1080/2162402X.2020.1859263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Mostafa GA, Ibrahim HM, Al Sayed Shehab A, Gendy YGE, Aly DMM, Shousha GAH. Up-regulated serum levels of soluble CD25 and soluble CD163 in pediatric patients with SARS-CoV-2. Eur J Pediatr 2022. [PMID: 35233677 DOI: 10.1007/s00431-022-04398-8] [Reference Citation Analysis]
15 Tian X, Aiyer KTS, Kapsenberg JM, Roelen DL, van der Hoorn ML, Eikmans M. Uncomplicated oocyte donation pregnancies display an elevated CD163-positive type 2 macrophage load in the decidua, which is associated with fetal-maternal HLA mismatches. Am J Reprod Immunol 2021;:e13511. [PMID: 34738274 DOI: 10.1111/aji.13511] [Reference Citation Analysis]
16 Cortes JR, Filip I, Albero R, Patiño-Galindo JA, Quinn SA, Lin WW, Laurent AP, Shih BB, Brown JA, Cooke AJ, Mackey A, Einson J, Zairis S, Rivas-Delgado A, Laginestra MA, Pileri S, Campo E, Bhagat G, Ferrando AA, Rabadan R, Palomero T. Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma. Cell Rep 2022;39:110695. [PMID: 35443168 DOI: 10.1016/j.celrep.2022.110695] [Reference Citation Analysis]
17 Wang X, Wu Y, Gu J, Xu J. Tumor-associated macrophages in lung carcinoma: From mechanism to therapy. Pathol Res Pract 2021;229:153747. [PMID: 34952424 DOI: 10.1016/j.prp.2021.153747] [Reference Citation Analysis]
18 Mázló A, Kovács R, Miltner N, Tóth M, Veréb Z, Szabó K, Bacskai I, Pázmándi K, Apáti Á, Bíró T, Bene K, Rajnavölgyi É, Bácsi A. MSC-like cells increase ability of monocyte-derived dendritic cells to polarize IL-17-/IL-10-producing T cells via CTLA-4. iScience 2021;24:102312. [PMID: 33855282 DOI: 10.1016/j.isci.2021.102312] [Reference Citation Analysis]
19 Li J, Kim SY, Lainez NM, Coss D, Nair MG. Macrophage-Regulatory T Cell Interactions Promote Type 2 Immune Homeostasis Through Resistin-Like Molecule α. Front Immunol 2021;12:710406. [PMID: 34349768 DOI: 10.3389/fimmu.2021.710406] [Reference Citation Analysis]
20 Kovacs L, Davis RA, Ganguly T, Chammas R, Sutcliffe JL. Repurposing an atherosclerosis targeting peptide for tumor imaging. Biomed Pharmacother 2022;145:112469. [PMID: 34864315 DOI: 10.1016/j.biopha.2021.112469] [Reference Citation Analysis]
21 Malik A, Thanekar U, Amarachintha S, Mourya R, Nalluri S, Bondoc A, Shivakumar P. "Complimenting the Complement": Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma. Front Oncol 2020;10:627701. [PMID: 33718121 DOI: 10.3389/fonc.2020.627701] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]